Skip to main
NHI

NHI Stock Forecast & Price Target

NHI Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 17%
Buy 50%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

National Health Investors is expected to benefit from the growing demand for senior housing and skilled nursing facilities. Their strong focus on this sector and their diverse portfolio of properties provide a stable source of revenue. The recent shift in portfolio composition to reduce exposure to skilled nursing further strengthens the company's outlook and could lead to higher stock returns. However, there is a risk of potential disruption to government reimbursements, which could hinder the company's expected growth and stock performance.

Bears say

National Health Investors is facing near-term dilution due to a portfolio sale, resulting in a decline in FFO estimates for 2026 and 2027. Additionally, the company's reliance on rental income and relatively low-leveraged balance sheet may limit its growth potential. Furthermore, the recent departure of board members and the sale of a portion of its portfolio may reduce potential conflicts of interest, but also exposes the company to operator concentration risk. With a declining normalized FFOps for 2026 and some growth expected in 2027, the company may face challenges in increasing shareholder value in the long-term.

NHI has been analyzed by 6 analysts, with a consensus rating of Buy. 17% of analysts recommend a Strong Buy, 50% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Health Investors (NHI) Forecast

Analysts have given NHI a Buy based on their latest research and market trends.

According to 6 analysts, NHI has a Buy consensus rating as of Jul 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $83.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $83.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Health Investors (NHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.